CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹936 Cr | ₹634 Cr | ₹567 Cr | ₹743 Cr | ₹622 Cr |
What is the latest Contingent Liabilities ratio of CIPLA ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹936 Cr |
Mar2024 | ₹634 Cr |
Mar2023 | ₹567 Cr |
Mar2022 | ₹743 Cr |
Mar2021 | ₹622 Cr |
How is Contingent Liabilities of CIPLA Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹936 Cr | 47.65 | |
Mar2024 | ₹634 Cr | 11.90 | |
Mar2023 | ₹567 Cr | -23.73 | |
Mar2022 | ₹743 Cr | 19.41 | |
Mar2021 | ₹622 Cr | - |
Compare Contingent Liabilities of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹127,264.9 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,342.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,555.0 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,898.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,394.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics | |
MANKIND PHARMA | ₹109,835.0 Cr | 3% | 6.2% | 7.5% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 1.8% |
1.9% |
-5.6% |
SENSEX | 0.9% |
1.2% |
-0.4% |
You may also like the below Video Courses